Cargando…

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation

AIMS: In patients undergoing catheter ablation for atrial fibrillation (AF), direct oral anticoagulants (DOACs) are as effective and safe as the vitamin K antagonist (VKA) warfarin. Phenprocoumon has a different pharmacokinetic profile compared with warfarin and is the most used VKA in Germany. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gjermeni, Diona, Saglam, Nertila Poci, Olivier, Christoph B, Kühlkamp, Volker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329261/ https://www.ncbi.nlm.nih.gov/pubmed/37427356 http://dx.doi.org/10.1093/ehjopen/oead065

Ejemplares similares

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
por: Murakawa, Yuji, et al.
Publicado: (2017)

Vitamin-K-antagonist phenprocoumon versus direct oral anticoagulants in patients with atrial fibrillation: a real-world analysis of German claims data
por: Warkentin, Lisette, et al.
Publicado: (2023)

The new era of atrial fibrillation treated by direct oral anticoagulants and catheter ablation—Comment on the “HAF‐NET Registry”
por: Yoshiga, Yasuhiro, et al.
Publicado: (2019)

Uninterrupted Direct Oral Anticoagulants Without a Change in Regimen for Catheter Ablation for Atrial Fibrillation Is an Acceptable Protocol
por: Oshima, Tsukasa, et al.
Publicado: (2021)

Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
por: Warkentin, Lisette, et al.
Publicado: (2022)

Comparison of direct oral anticoagulants and warfarin regarding midterm adverse events in patients with atrial fibrillation undergoing catheter ablation
por: Sagawa, Yuichiro, et al.
Publicado: (2018)

Phenprocoumon based anticoagulation is an underestimated factor in the pathogenesis of calciphylaxis
por: Russ, Philipp, et al.
Publicado: (2019)

Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin
por: Shin, Dong Geum, et al.
Publicado: (2016)

Safety and Efficacy of Uninterrupted Oral Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation with Different Techniques
por: Schiavone, Marco, et al.
Publicado: (2023)

Omitting transesophageal echocardiography before catheter ablation of atrial fibrillation or left sided atrial tachycardia in patients on oral anticoagulation
por: Maslova, V, et al.
Publicado: (2023)

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Gjermeni, Diona, et al.
Publicado: (2022)

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2015)

Catheter Ablation for Atrial Fibrillation
por: Gauri, Andre J, et al.
Publicado: (2003)

Oral Anticoagulation Discontinuation Following Catheter Ablation of Typical Atrial Flutter
por: Alqam, Bilal M., et al.
Publicado: (2021)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Utilization of Anticoagulants in Nonvalvular Atrial Fibrillation Before and After Catheter Ablation at Shanghai, China
por: Tingting, Chen, et al.
Publicado: (2019)

Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation
por: Yamaji, Hirosuke, et al.
Publicado: (2017)

Cryoballoon Catheter Ablation in Atrial Fibrillation
por: Ozcan, Cevher, et al.
Publicado: (2011)

Catheter ablation of atrial fibrillation in the elderly
por: Lioni, Louiza, et al.
Publicado: (2014)

Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
por: Al-Jazairi, M. I. H., et al.
Publicado: (2019)

Activated Clotting Time Monitoring during Atrial Fibrillation Catheter Ablation: Does the Anticoagulant Matter?
por: Martin, Anne-Céline, et al.
Publicado: (2020)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes
por: Yamaji, Hirosuke, et al.
Publicado: (2019)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
por: Prídavková, Dana, et al.
Publicado: (2019)

Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021)

Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters
por: Geisen, Christof, et al.
Publicado: (2010)

Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Maraj, Ilir, et al.
Publicado: (2018)

Intracardiac Echocardiography during Catheter-Based Ablation of Atrial Fibrillation
por: Biermann, Jürgen, et al.
Publicado: (2012)

Catheter ablation of atrial fibrillation in elderly population
por: Kautzner, Josef, et al.
Publicado: (2017)

Atrial Fibrillation Mechanisms and Implications for Catheter Ablation
por: Cheniti, Ghassen, et al.
Publicado: (2018)

Catheter ablation in patients with persistent atrial fibrillation
por: Kirchhof, Paulus, et al.
Publicado: (2017)

Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians
por: Mujović, Nebojša, et al.
Publicado: (2017)

Atrial fibrillation – QT interval and catheter ablation
por: Mann, Linda, et al.
Publicado: (2020)

Carbon footprint of atrial fibrillation catheter ablation
por: Ditac, Geoffroy, et al.
Publicado: (2022)

Comparison of effectiveness and safety between uninterrupted direct oral anticoagulants with and without switching to dabigatran in atrial fibrillation ablation
por: Harada, Masahide, et al.
Publicado: (2020)

Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation: A meta‐analysis
por: Basu‐Ray, Indranill, et al.
Publicado: (2021)

Large Circular Ring Catheter Ablation Versus Anatomically Guided Ablation of Atrial Fibrillation: Back to the Future for Successful Catheter Ablation of Atrial Fibrillation?
por: Pak, Hui-Nam
Publicado: (2011)

Figure-of-eight suture for venous hemostasis in fully anticoagulated patients after atrial fibrillation catheter ablation
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2017)

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Drug interaction: Omeprazole and Phenprocoumon
por: Enderle, Christa, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_b9ioklfaj9bumr21fkbrijp2br